跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
cabozantinib malate
首页
药物
cabozantinib malate
cabozantinib malate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL}-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE
EP 3738952 A1
申请人: EXELIXIS INC
优先权: 2014
CN
EP
US
7 件公开
PROCESS FOR PREPARATION OF CABOZANTINIB
EP 4313048 A1
申请人: BIOCON LTD
优先权: 2021
EP
US
WO
3 件公开
PHARMACEUTICAL COMPOSITION OF CABOZANTINIB
EP 4791402 A1
申请人: MSN LABORATORIES PRIVATE LTD R&D CENTER
优先权: 2023
EP
WO
2 件公开
Polymorphs of cabozantinib (S)-malate and cabozantinib free base
US 9815789 B2
申请人: MYLAN LABS LTD
优先权: 2014
US
Cabozantinib malate compound and medicine composition therewith
CN 105503717 A
申请人: JIANGSU AOSAIKANG PHARM CO LTD
优先权: 2014
CN
Cabozantinib malate crystal form II
CN 108341773 A
申请人: NANJING HUAWE MEDICAL TECH DEVELOPMENT CO LTD
优先权: 2017
CN
Preparation method of cabozantinib s-malate tablets
CN 107951850 A
申请人: SHENZHEN MAIN LUCK PHARMACEUTICALS INC
优先权: 2017
CN
Preparation method of impurities in synthesis of cabozantinib malate
CN 110423218 A
申请人: XINXIANG SHUANGLU MEDICINE CO LTD
优先权: 2019
CN
Cabozantinib malate tablet and preparation method thereof
CN 115487157 A
申请人: NANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD
优先权: 2021
CN
Preparation method of L-cabozantinib malate N-2 crystal form
CN 118851999 A
申请人: SHANGHAI HUILUN PHARMACEUTICAL CO LTD
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈